Crossmark

Biosimilars: A New Scenario in Biologic Therapies

Crossref DOI link: https://doi.org/10.1016/j.reumae.2016.05.014

Published Print: 2017-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Serra López-Matencio, José M.

Morell Baladrón, Alberto

Castañeda, Santos
License Information

Text and Data Mining valid from 2017-09-01
More Information

This article is maintained by: Elsevier

Article Title: Biosimilars: A New Scenario in Biologic Therapies

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2016.05.014

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2016.05.013

Content Type: article

Copyright: © 2015 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.